Search research articles
Contact Us
Filters
Showing results (301-310 of 326) with videos related to
Page
of 33
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2021
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
Meredith S Irwin, Arlene Naranjo, Fan F Zhang, et al.
Nature Medicine
|
March 3, 2009
Regulation of endocytosis via the oxygen-sensing pathway
Yi Wang, Olga Roche, Mathew S Yan, et al.
Nature Genetics
|
May 10, 2000
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
M C Marin, C A Jost, L A Brooks, et al.
Cancer Research
|
April 16, 2020
Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma
Balakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi, et al.
Cell Reports
|
August 4, 2023
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma
Miriam I Rosenberg, Erez Greenstein, Martin Buchkovich, et al.
Pediatric Blood & Cancer
|
April 1, 2018
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial
Navin Pinto, Steven G DuBois, Araz Marachelian, et al.
ERJ Open Research
|
March 17, 2022
Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel
Elena Kum, Gordon H Guyatt, Caroline Munoz, et al.
Nature Communications
|
January 16, 2019
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation
Yoshihito Kano, Teklab Gebregiworgis, Christopher B Marshall, et al.
Nature Medicine
|
June 21, 2011
Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia
Ryan C Russell, Roxana I Sufan, Bing Zhou, et al.
Journal of Pediatric Surgery
|
September 24, 2024
Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531
Erin G Brown, E Stanton Adkins, Peter Mattei, et al.
Page
of 33
Search research articles
Search
Showing results (301-310 of 326) with videos related to
Sort By:
Page
of 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2021
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
Meredith S Irwin, Arlene Naranjo, Fan F Zhang, et al.
Nature Medicine
|
March 3, 2009
Regulation of endocytosis via the oxygen-sensing pathway
Yi Wang, Olga Roche, Mathew S Yan, et al.
Nature Genetics
|
May 10, 2000
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
M C Marin, C A Jost, L A Brooks, et al.
Cancer Research
|
April 16, 2020
Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma
Balakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi, et al.
Cell Reports
|
August 4, 2023
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma
Miriam I Rosenberg, Erez Greenstein, Martin Buchkovich, et al.
Pediatric Blood & Cancer
|
April 1, 2018
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial
Navin Pinto, Steven G DuBois, Araz Marachelian, et al.
ERJ Open Research
|
March 17, 2022
Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel
Elena Kum, Gordon H Guyatt, Caroline Munoz, et al.
Nature Communications
|
January 16, 2019
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation
Yoshihito Kano, Teklab Gebregiworgis, Christopher B Marshall, et al.
Nature Medicine
|
June 21, 2011
Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia
Ryan C Russell, Roxana I Sufan, Bing Zhou, et al.
Journal of Pediatric Surgery
|
September 24, 2024
Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531
Erin G Brown, E Stanton Adkins, Peter Mattei, et al.
Page
of 33